Intermittent Catheter Market Currently Valued at $230 Million and Set to Double by 2014

TORONTO, Oct. 26 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, reimbursement changes have caused the demand for intermittent catheters to increase significantly. In April 2008, Medicare changed reimbursement to cover up to 200 catheters per month, instead of the previous 4 that it covered. Over the past two years, market growth has been fueled by patients who have switched to a single-use regimen. There is, however, still tremendous growth potential in this market because the majority of patients who regularly use intermittent catheters are still generally comfortable reusing catheters because this has been a standard practice for many years. These patients typically use only four or five catheters per month.  

Supported by its strong sales force, Coloplast had over 50% of the market in 2009, with C.R. Bard, Astra Tech, Rusch, and Hollister also accounting for a notable share in this segment that year. A substantial sales force is necessary to develop appropriate relationships with health care providers -- in order to ensure that prescriptions are being written specifically for a manufacturer's device -- and with distributors -- in order to ensure that they promote specific devices to end users. The dominant presence of larger competitors in this market and their existing relationships with health care providers and distributors may therefore prevent smaller competitors from entering or being more successful in this segment.

"In order to be successful, manufacturers will need to develop these relationships with health care providers and medical product distributors," says Aaron McCracken, Principal Analyst at MRG. "Companies will also need to brand their products directly to patients to ensure that they ask for a specific brand when ordering catheters from a distributor."

MRG's US Markets for Urological Devices 2010 report provides critical insight into trends that will fuel and limit market growth for urological devices in the US. The report includes a breakdown of unit volumes, average selling prices, and market values for urinary incontinence devices (for example, urinary catheters and vaginal slings), urological endoscopes, and devices used to treat conditions such as kidney stones, prostate cancer, prostatic hyperplasia, and erectile dysfunction.  

Webinar

On Wednesday November 17, at 11:00 am eastern time, MRG is offering a webinar for purchasers of the US Markets for Urological Devices 2010 report.  For more information, please contact Amy Krohn at 416-364-7776 ext. 101 or [email protected].

About Millennium Research Group

Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer behavior tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

SOURCE Millennium Research Group

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED